Management of MS in a pediatric patient— especially in a younger child—requires a careful approach that differs in many respects from that of adults with MS. There is a need to consider the impact of treatment on the developing immune system and brain and over a longer-term disease course. This special supplement addresses the challenges and considerations that clinicians face managing MS in the pediatric patient.
Eluen Ann Yeh, MD, MA, Staff Neurologist, The Hospital for Sick Children, Toronto, ON, Canada
Jennifer Graves, MD, PhD, University of California – San Francisco, San Francisco, California
Jennifer Boyd, RN, MHSc, MSCN, Clinical Nurse Specialist, The Hospital for Sick Children, Toronto, ON, Canada
This activity is jointly provided by the Consortium of Multiple Sclerosis Centers and Delaware Media Group.
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation